Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Sun Pharma receives USFDA nod for anti-cholesterol drug

      Sun Pharma receives USFDA nod for anti-cholesterol drug

      Ruby Khatun Khatun14 Jun 2017 11:43 AM IST
      New Delhi: Drug major Sun Pharmaceutical Industries' wholly-owned subsidiary has received nod from the US health regulator for its generic version of...
      Strides Shasun gets USFDA nod for pain relieving drug

      Strides Shasun gets USFDA nod for pain relieving drug

      Ruby Khatun Khatun13 Jun 2017 12:17 PM IST
      New Delhi: Drug firm Strides Shasun has received the US health regulator's nod for Amantadine Hydrochloride tablets, used in the treatment of...
      Kieran Murphy appointed as president and CEO of GE Healthcare

      Kieran Murphy appointed as president and CEO of GE Healthcare

      Ruby Khatun Khatun13 Jun 2017 12:14 PM IST
      BOSTON: GE Chairman and CEO Jeff Immelt announced the appointment of Kieran Murphy as president and CEO of GE Healthcare, effective immediately.Murphy...
      Bayer, Johnson & Johnson win second US trial over Xarelto bleeding risks

      Bayer, Johnson & Johnson win second US trial over Xarelto bleeding risks

      Ruby Khatun Khatun13 Jun 2017 12:13 PM IST
      A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the second trial to stem from thousands of lawsuits blaming injuries on...
      Sahajanand Medical Technologies Announces enrolment of the First Patient in EverOCT Study in India

      Sahajanand Medical Technologies Announces enrolment of the First Patient in EverOCT Study in India

      Ruby Khatun Khatun13 Jun 2017 11:12 AM IST
      Mumbai: SMT (Sahajanand Medical Technologies Pvt. Ltd.) India’s largest manufacturer of cardiovascular medical stents, has announced the enrolment of...
      After Stents and Catherter, FDA moves Scanner to Intraocular Lenses

      After Stents and Catherter, FDA moves Scanner to Intraocular Lenses

      Ruby Khatun Khatun13 Jun 2017 9:17 AM IST
      New Delhi: After making revelations of unjust profit margins on cardiac catheters last week, the Mahashtra FDA was recently seen making more...
      FDA rejects Coherus

      FDA rejects Coherus' biosimilar for Amgen's Neulasta

      Ruby Khatun Khatun13 Jun 2017 9:12 AM IST
      n" style="transform: translate3d(0px, 0px, 0px);"Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the...
      Eris Lifesciences enters primary market through IPO

      Eris Lifesciences enters primary market through IPO

      Ruby Khatun Khatun12 Jun 2017 3:38 PM IST
      Mumbai: Eris Lifesciences will be venturing in the primary market on Friday 16th June 2017, with an offer for sale (OFS) of up to 2.89 crore equity...
      Zydus Nesher Pharmaceuticals gets FDA nod for antifungal drug

      Zydus Nesher Pharmaceuticals gets FDA nod for antifungal drug

      Ruby Khatun Khatun12 Jun 2017 11:30 AM IST
      New Delhi: Zydus Group firm Cadila Healthcare said its subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical...
      Biocon, Mylan Present Clinical Data on Insulin Glargine at American Diabetes Associations 77th Scientific Sessions

      Biocon, Mylan Present Clinical Data on Insulin Glargine at American Diabetes Associations 77th Scientific Sessions

      Ruby Khatun Khatun12 Jun 2017 11:29 AM IST
      Mylan N.V. and Biocon Ltd. announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE studies at the...
      Norwest Venture Invests Rs 9.65 crore each in 2 Health Startups-Multiplier Solutions and ABI Health

      Norwest Venture Invests Rs 9.65 crore each in 2 Health Startups-Multiplier Solutions and ABI Health

      Ruby Khatun Khatun12 Jun 2017 11:25 AM IST
      New Delhi: Norwest Venture Partners, a multi-stage investment firm has invested $1.5 million (Rs 9.65 crore), each in Hyderabad-based Multiplier...
      Roche CEO still optimistic on new breast cancer drug

      Roche CEO still optimistic on new breast cancer drug

      Ruby Khatun Khatun12 Jun 2017 11:21 AM IST
      VIENNA: Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok